The Effect of RNS60 on ALS Biomarkers

Clinical trial NCT03456882 · COMPLETED

Trial details

NCT number: NCT03456882
Sponsor: Mario Negri Institute for Pharmacological Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2017-05-30
Primary completion: 2020-11-23
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.